UK/XIF5/1017/0353

Date of preparation: March 2018

Information intended for healthcare professionals only. This supplement has been commissioned by Norgine Pharmaceuticals Limited. Norgine Pharmaceuticals Limited suggested the topic and author, commented on the author brief, and funded production of the supplement. Content has also been checked for factual accuracy to ensure it is fair and balanced, and to ensure its compliance with appropriate regulations. The sponsorship fee included the honorarium for the author. Final editorial control of the supplement has remained with the author and Guidelines. The views and opinions in this supplement are not necessarily those of Norgine Pharmaceuticals Limited or of Guidelines, it’s publishers, advisers, or advertisers. Prescribing information can be found on page 8 of the PDF.

Click here for prescribing information

Click here to download the supplement

If the PDF does not load within 5 seconds, please refresh the page.

UK/XIF5/1017/0353
Date of preparation: March 2018

Click here for prescribing information for Targaxan (rifaximin-α)

Best practice in liver care